Second Quarter 2025 Investor Presentation The Exchange at Gwinnett | Atlanta, GA Highlights Q2 2025 Highlights | $0.45 | Core FFO Per Share | | --- | --- | | $213 | Implied property value per square foot | | $19.35 | Cash ABR PSF | | ~190,000 | Square feet of comparable leasing activity | | 22% | Comparable leasing spread | | 83% | ABR from Georgia, Texas, Florida & North Carolina | | 93.9% | Leased Occupancy | | $4.6M | SNO Pipeline – 4.6% of in-place ABR | | 0.9% | Quarterly same-property NOI growth | | $ ...

Financial Performance - Q3 2025 - Net sales reached $1.19 billion, a decrease of 1% compared to Q3 2024[56] - Adjusted gross margin rate improved to 32.1%, an increase of 290 bps from Q3 2024[56] - Adjusted net income was $151.5 million, compared to $133.8 million in Q3 2024[56] - Adjusted diluted EPS was $2.59, compared to $2.31 in Q3 2024[56] - Adjusted EBITDA was $256.1 million, compared to $236.8 million in Q3 2024[56] Segment Performance - U S Consumer net sales increased by 1% in Q3 2025[64] - Hawthorne net sales decreased by 54% in Q3 2025[64] - Other segment net sales increased by 8% in Q3 2025[64] Strategic Focus & Outlook - The company aims for sustainable net sales growth, averaging 3% annually, focused on the consumer lawn & garden business[19] - The company expects approximately $75 million in additional supply chain cost savings over fiscal years 2026 and 2027[45] - The company anticipates approximately $250 million in free cash flow for fiscal year 2025[60] - The company projects an adjusted gross margin rate of approximately 30% for fiscal year 2025, targeting mid-30% by fiscal year 2027[60] - E-commerce penetration of POS dollars is at approximately 10% year-to-date[41]

July 2025 Investor Presentation newport harbor island resort INVESTOR PRESENTATION JULY 2025 Forward-Looking Statements This presentation contains forward-looking statements that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of Pebblebrook Hotel Trust's (the "Company" or "Pebblebrook") business, financial condition, liquidity, results of operations, plans and objectives. These forward-looking statements are based on the ...

INVESTOR PRESENTATION July 2025 Forward-Looking Statements Except for historical information contained herein, the statements and information in this presentation, including the oral statements made in connection herewith, are forward- looking statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include the words "may," "could," "confi ...

Financial Performance - Net income available to common shareholders was $873 million, or $091 per share, excluding restructuring and merger-related expenses and day 1 provision for credit losses on acquired loans[6, 39] - Net interest margin improved to 359%, up 64 basis points year-over-year and 24 basis points quarter-over-quarter[6, 23] - Return on average tangible equity was 1716%, an increase of 838 basis points compared to the same quarter last year[8] - Efficiency ratio improved to 555%, driven by the benefits of the PFC acquisition and positive operating leverage[7] Loan and Deposit Growth - Total loans increased 536% year-over-year to $188 billion, reflecting $59 billion of loans from PFC and organic growth[6, 10, 11] - Total deposits increased 575% year-over-year to $212 billion, including $69 billion of deposits from PFC and organic growth[13, 15] - Year-over-year organic deposit growth was $850 million, or 63%, fully funding organic loan growth[15] Asset Quality and Capital - Non-performing assets to total assets ratio was 031%[6, 8] - Tangible common equity to tangible assets ratio was 760%[6, 19] - The allowance for credit losses on loans was $2239 million, providing a coverage ratio of 119%[31] Securities Portfolio - Total securities were $439 billion, representing 16% of total assets[17] - The securities portfolio had a weighted average yield of 321%[19]

Financial Performance - Verisk reported revenue of $773 million, a 7.8% year-over-year increase[12] - Adjusted EBITDA reached $445 million, up 11.9% year-over-year[12] - Adjusted EBITDA margin expanded by 220 basis points to 57.6%[9, 12] - Diluted Adjusted EPS increased by 8.0% to $1.88[9, 12] - Free cash flow grew by 22.6% to $189 million[9, 12] Revenue Breakdown - Underwriting revenue increased by 7.7% organically[9] - Claims revenue increased by 8.3% organically[9] - Subscription revenue grew by 9.3% organically, accounting for 81% of total revenue[9, 18] - Transactional revenue grew by 1.8% organically, accounting for 17% of total revenue[9, 18] Capital Allocation - Verisk returned $163 million to shareholders through dividends and share repurchases[8] - The company repurchased $100 million of shares in 2Q25[28] - A dividend of $0.45 per share was paid in 2Q25, totaling $63 million[28] Acquisitions and Outlook - Verisk closed the acquisition of SuranceBay for $163 million[8, 28] - Verisk signed an agreement to acquire AccuLynx for $2.35 billion[8, 28] - The company increased its revenue outlook for 2025 to $3.09 billion - $3.13 billion[8, 24]

Financial Performance - Q2 2025 - Revenues reached $5 billion with 2% organic growth[10] - Organic orders grew by 3% year-over-year[10] - Adjusted EBIT was $729 million with a 14.6% margin, a decrease of 80 bps year-over-year[10] - Adjusted EPS was $1.06, a 6% increase year-over-year[10] - Free cash flow was $7 million, an increase of $189 million year-over-year[10] Segment Results - Q2 2025 - Imaging revenues were $2.204 billion, with organic revenue growth of 1%[16] - Advanced Visualization Solutions (AVS) revenues were $1.289 billion, with organic revenue growth of 2%[20] - Patient Care Solutions (PCS) revenues were $778 million, with organic revenue flat at 0%[24] - Pharmaceutical Diagnostics (PDx) revenues were $729 million, with organic revenue growth of 5%[29] Outlook and Tariffs - The company is raising its 2025 Adjusted EPS guidance to $4.43 - $4.63[9, 40] - The company expects a net tariff impact of approximately $265 million, or ~$0.45 per share[40] - The company has mitigated approximately 50% of gross tariffs[39] - The company is updating its 2025 organic revenue growth outlook to ~3%[44] - The company is updating its 2025 Adjusted EBIT Margin to 15.2% - 15.4%[44] - The company is updating its 2025 Free Cash Flow to at least $1.4 billion[44]

Q2 2025 Financial Results July 30, 2025 1 Forward-looking Statements 2 This presentation contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include but are not limited to statements relating to: our financial guidance for the third quarter of 2025 and underlying assumptions; our customer relationship flywheel; the impact of AI, ML, and LLMs; our ability to become a leader in agentic shopping; our product development investments and marketing ini ...

Company Overview - InMode is a leading global provider of innovative, minimally-invasive aesthetic and wellness solutions[5] - The company has a broad radiofrequency (RF) based portfolio, including capital equipment and consumables[5] - InMode sells in 89 countries[7] - The company has 669 employees worldwide, including 297 direct sales reps and a 42 person R&D team[12] Financial Performance (Q2 2025) - Q2-2025 Revenue was $95.6 million[7] - Q2-2025 Non-GAAP Net Income was $30.1 million[7] - Q2-2025 Non-GAAP Gross Margin was 80%[7] - Q2-2025 Non-GAAP Diluted Earning per Share was $0.47[7] Technology and Solutions - InMode addresses the "Treatment Gap" with minimally-invasive technologies[20] - The company has 10 patented technologies across 11 product families[7] - Clinical studies demonstrate RFAL technology can achieve up to 40% contraction of the heated tissue volume[34] - InMode has launched multiple innovative product platforms since 2010[86]

Financial Results for Q2 2025 July 30, 2025 Safe Harbor Sales of $652M | Non-GAAP Gross Margin(1) of 57.3% | Non-GAAP EPS(1) of $0.57 | EPS Above Mid Guidance This presentation contains forward-looking statements including statements regarding Teradyne's future business prospects, financial performance or position and results of operations. You can identify forward-looking statements by their use of forward-looking words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," ...